FDA 21 CFR Part 820 Compliance for Medical Devices in Algeria | Operon Strategist

 Operon Strategist provides expert consulting for FDA 21 CFR Part 820 Quality System Regulation (QSR) compliance, helping Algerian medical device manufacturers export successfully to the U.S. market. FDA 21 CFR Part 820 outlines current Good Manufacturing Practices (cGMP), covering design, manufacturing, labeling, packaging, and servicing of medical devices. While FDA does not issue a certificate, compliance is verified through inspections, making it critical for U.S. market entry. Operon Strategist supports Algerian companies with gap analysis, QMS documentation, staff training, and mock audits to ensure inspection readiness. Our specialized FDA consultants also assist with 510(k) submissions, combination product registrations, and post-inspection corrective actions. With global expertise and proven methodologies, Operon Strategist ensures your devices meet FDA standards, safeguarding quality, compliance, and regulatory approval.

Read More